Oncology
Hemoglobin and platelets are associated with overall survival in patients with myelofibrosis following allogeneic HSCT.
Treatment-naïve myelofibrosis patients who received navitoclax plus ruxolitinib saw a significant reduction in spleen ...
The Fellow on Call group discusses the fundamentals of chemotherapy, including basic terminology, optimal dosing, and more.
For patients with breast cancer, a regimen of epirubicin followed by adjuvant chemotherapy is associated with worse QOL.
Drs. Chadi Nabhan and Jennifer Mack discuss the delicate art of delivering bad news to patients with cancer.
Moshe Chasky and Allen Lord Terzian, of Alliance Cancer Specialists, join Dr. Chadi Nabhan to discuss a high-stakes lawsuit.
Drs. Vishwas Paralkar and Sophia Gayle discuss CBX-15, a novel therapy for triple-negative breast cancer.
The group discusses chimeric antigen receptor T-cell therapy, bispecific T-cell engagers, and autologous transplants.
The Fellow on Call team discusses the management of advanced-stage DLBCL, including the role of CNS prophylaxis and more.
The Fellow on Call group discusses the early management of diffuse large B-cell lymphoma.
Advertisement
Expert Interviews on Oncology
Advertisement
DocWire News delivers the latest medical industry news, giving health care professionals the curated content most relevant to their fields and practices.
Get the latest medical updates and insights straight to your inbox.
